Johnson Financial Group Inc (Wisconsin)’s Pacira BioSciences PCRX Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3	Closed	–	–	778
2021 Q4	$0	Sell	3 -3	-50%	-$165	﹤0.01%	818
2021 Q3	$0	Hold	6	–	–	﹤0.01%	783
2021 Q2	$0	Buy	+6	New	+$380	﹤0.01%	791
2016 Q3	–	Sell	-274	Closed	-$9K	–	734
2016 Q2	$9K	Buy	274 +225	+459%	+$11.1K	﹤0.01%	672
2016 Q1	$3K	Hold	49	–	–	﹤0.01%	682
2015 Q4	$4K	Hold	49	–	–	﹤0.01%	700
2015 Q3	$2K	Hold	49	–	–	﹤0.01%	771
2015 Q2	$3K	Buy	+49	New	+$3.86K	﹤0.01%	796
2013 Q3	–	Sell	-122	Closed	-$4K	–	703
2013 Q2	$4K	Buy	+122	New	+$3.53K	﹤0.01%	640

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s PCRX Position: Q1 2022 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Pacira BioSciences (PCRX) in Q1 2022, closing a stake of 3 shares.

Johnson Financial Group Inc (Wisconsin) first reported a position in PCRX in Q2 2013 and held it in 9 quarters. The position peaked at $9K in Q2 2016. 301 funds tracked by Wall St. Rank hold PCRX as of Q1 2022.

Johnson Financial Group Inc (Wisconsin) reported no remaining Pacira BioSciences position as of Q1 2022 after selling out during the quarter.
Johnson Financial Group Inc (Wisconsin) sold 3 Pacira BioSciences shares in Q1 2022.
Johnson Financial Group Inc (Wisconsin) first reported a position in Pacira BioSciences in Q2 2013 and held it in 9 quarters.
Johnson Financial Group Inc (Wisconsin)'s Pacira BioSciences position peaked at $9K in Q2 2016.
301 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2022.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2022, filed 16 May 2022.